| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Magnetic Resonance Imaging | 61 | 2026 | 2324 | 6.470 |
Why?
|
| Cerebrovascular Circulation | 44 | 2026 | 228 | 5.870 |
Why?
|
| Dependovirus | 26 | 2026 | 760 | 5.260 |
Why?
|
| Genetic Therapy | 24 | 2026 | 852 | 4.980 |
Why?
|
| Spin Labels | 32 | 2026 | 44 | 4.520 |
Why?
|
| Brain | 45 | 2026 | 1672 | 4.410 |
Why?
|
| Imaging, Three-Dimensional | 12 | 2026 | 312 | 4.140 |
Why?
|
| Genetic Vectors | 24 | 2026 | 929 | 3.540 |
Why?
|
| Magnetic Resonance Angiography | 16 | 2026 | 202 | 2.370 |
Why?
|
| Blood-Brain Barrier | 11 | 2026 | 99 | 2.080 |
Why?
|
| Arteries | 7 | 2023 | 88 | 1.930 |
Why?
|
| Gene Transfer Techniques | 9 | 2025 | 325 | 1.920 |
Why?
|
| Cerebral Cortex | 6 | 2026 | 276 | 1.730 |
Why?
|
| Image Processing, Computer-Assisted | 11 | 2026 | 715 | 1.710 |
Why?
|
| Cerebrovascular Disorders | 5 | 2025 | 89 | 1.640 |
Why?
|
| Codon, Nonsense | 6 | 2024 | 62 | 1.540 |
Why?
|
| Brain Mapping | 7 | 2026 | 247 | 1.510 |
Why?
|
| Nervous System Diseases | 2 | 2024 | 109 | 1.440 |
Why?
|
| Mucopolysaccharidosis I | 4 | 2022 | 7 | 1.420 |
Why?
|
| Humans | 114 | 2026 | 65826 | 1.390 |
Why?
|
| Cognitive Dysfunction | 9 | 2025 | 360 | 1.360 |
Why?
|
| Perfusion Imaging | 3 | 2021 | 25 | 1.340 |
Why?
|
| Gene Editing | 8 | 2024 | 331 | 1.230 |
Why?
|
| White Matter | 10 | 2025 | 138 | 1.210 |
Why?
|
| Liver | 4 | 2025 | 875 | 1.190 |
Why?
|
| Cerebral Arteries | 4 | 2020 | 45 | 1.190 |
Why?
|
| Signal-To-Noise Ratio | 6 | 2026 | 67 | 1.150 |
Why?
|
| Neuroimaging | 5 | 2026 | 170 | 1.140 |
Why?
|
| Iduronidase | 3 | 2022 | 5 | 1.140 |
Why?
|
| 3-Methyl-2-Oxobutanoate Dehydrogenase (Lipoamide) | 2 | 2026 | 13 | 1.110 |
Why?
|
| Maple Syrup Urine Disease | 2 | 2026 | 24 | 1.090 |
Why?
|
| Disease Models, Animal | 12 | 2026 | 2329 | 1.090 |
Why?
|
| CRISPR-Cas Systems | 6 | 2024 | 369 | 1.060 |
Why?
|
| Magnetic Fields | 2 | 2018 | 6 | 1.050 |
Why?
|
| Animals | 43 | 2026 | 21489 | 1.040 |
Why?
|
| Recombination, Genetic | 3 | 2025 | 256 | 1.000 |
Why?
|
| RNA, Transfer | 2 | 2024 | 93 | 0.940 |
Why?
|
| Brain Ischemia | 3 | 2019 | 423 | 0.930 |
Why?
|
| Mice, Inbred C57BL | 10 | 2025 | 3504 | 0.900 |
Why?
|
| DNA, Circular | 1 | 2025 | 7 | 0.900 |
Why?
|
| Female | 62 | 2026 | 34414 | 0.880 |
Why?
|
| Capsid | 2 | 2025 | 104 | 0.880 |
Why?
|
| Choroid Plexus | 1 | 2025 | 16 | 0.880 |
Why?
|
| Male | 58 | 2026 | 31398 | 0.870 |
Why?
|
| Peptide-N4-(N-acetyl-beta-glucosaminyl) Asparagine Amidase | 1 | 2024 | 4 | 0.870 |
Why?
|
| Congenital Disorders of Glycosylation | 1 | 2024 | 7 | 0.860 |
Why?
|
| Mice | 29 | 2026 | 11185 | 0.860 |
Why?
|
| Capsid Proteins | 1 | 2025 | 107 | 0.840 |
Why?
|
| CADASIL | 5 | 2024 | 8 | 0.830 |
Why?
|
| Cerebral Small Vessel Diseases | 4 | 2024 | 15 | 0.830 |
Why?
|
| Motor Cortex | 2 | 2021 | 75 | 0.820 |
Why?
|
| Adult | 38 | 2026 | 17567 | 0.810 |
Why?
|
| Placenta | 3 | 2026 | 73 | 0.780 |
Why?
|
| Transcriptome | 1 | 2026 | 408 | 0.750 |
Why?
|
| Aging | 7 | 2026 | 784 | 0.740 |
Why?
|
| Stroke | 4 | 2023 | 1225 | 0.740 |
Why?
|
| Visual Cortex | 2 | 2021 | 29 | 0.720 |
Why?
|
| Homeostasis | 1 | 2025 | 383 | 0.720 |
Why?
|
| Anti-Mullerian Hormone | 5 | 2023 | 68 | 0.710 |
Why?
|
| Water | 6 | 2026 | 323 | 0.710 |
Why?
|
| Transduction, Genetic | 6 | 2025 | 242 | 0.710 |
Why?
|
| Phenotype | 3 | 2024 | 1236 | 0.700 |
Why?
|
| Algorithms | 8 | 2026 | 1060 | 0.680 |
Why?
|
| Rest | 6 | 2025 | 51 | 0.680 |
Why?
|
| Mice, Knockout | 3 | 2026 | 2168 | 0.660 |
Why?
|
| Spinal Cord | 3 | 2018 | 210 | 0.650 |
Why?
|
| Young Adult | 18 | 2026 | 4878 | 0.640 |
Why?
|
| Heterozygote | 3 | 2025 | 175 | 0.640 |
Why?
|
| Middle Cerebral Artery | 2 | 2024 | 53 | 0.620 |
Why?
|
| Image Interpretation, Computer-Assisted | 2 | 2020 | 190 | 0.610 |
Why?
|
| Image Enhancement | 3 | 2017 | 196 | 0.600 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 6 | 2026 | 172 | 0.570 |
Why?
|
| Ferrosoferric Oxide | 1 | 2018 | 18 | 0.560 |
Why?
|
| Motion | 5 | 2021 | 71 | 0.560 |
Why?
|
| Genes, Recessive | 1 | 2018 | 51 | 0.560 |
Why?
|
| Schizophrenia | 4 | 2025 | 279 | 0.550 |
Why?
|
| Infusions, Spinal | 1 | 2018 | 3 | 0.550 |
Why?
|
| Perfusion | 7 | 2021 | 83 | 0.550 |
Why?
|
| Blood Flow Velocity | 4 | 2019 | 79 | 0.540 |
Why?
|
| Ultrasonography, Doppler | 1 | 2017 | 29 | 0.530 |
Why?
|
| Echo-Planar Imaging | 2 | 2017 | 36 | 0.530 |
Why?
|
| Alzheimer Disease | 5 | 2025 | 773 | 0.530 |
Why?
|
| Staining and Labeling | 1 | 2018 | 128 | 0.520 |
Why?
|
| Transgenes | 5 | 2025 | 207 | 0.510 |
Why?
|
| Alleles | 1 | 2018 | 455 | 0.500 |
Why?
|
| Executive Function | 3 | 2026 | 71 | 0.490 |
Why?
|
| Reperfusion Injury | 1 | 2017 | 58 | 0.490 |
Why?
|
| Transcranial Magnetic Stimulation | 1 | 2016 | 29 | 0.490 |
Why?
|
| Aged | 28 | 2026 | 15141 | 0.490 |
Why?
|
| Hypercapnia | 5 | 2024 | 14 | 0.480 |
Why?
|
| Middle Aged | 30 | 2026 | 18491 | 0.470 |
Why?
|
| Biomarkers | 9 | 2025 | 1502 | 0.470 |
Why?
|
| Vascular Capacitance | 1 | 2015 | 3 | 0.460 |
Why?
|
| Hepatic Artery | 1 | 2015 | 23 | 0.460 |
Why?
|
| Hydrogen Sulfide | 1 | 2015 | 10 | 0.460 |
Why?
|
| Portal Vein | 1 | 2015 | 40 | 0.460 |
Why?
|
| Mechanotransduction, Cellular | 1 | 2015 | 29 | 0.450 |
Why?
|
| Aminoglycosides | 2 | 2012 | 11 | 0.440 |
Why?
|
| Muscles | 3 | 2019 | 179 | 0.440 |
Why?
|
| Lupus Nephritis | 1 | 2015 | 38 | 0.440 |
Why?
|
| Mutation | 4 | 2023 | 2674 | 0.420 |
Why?
|
| Glycosaminoglycans | 2 | 2011 | 20 | 0.420 |
Why?
|
| Apolipoprotein E4 | 2 | 2025 | 48 | 0.420 |
Why?
|
| Nitric Oxide | 1 | 2015 | 165 | 0.420 |
Why?
|
| Non-alcoholic Fatty Liver Disease | 1 | 2015 | 92 | 0.410 |
Why?
|
| Kidney | 2 | 2017 | 460 | 0.400 |
Why?
|
| Endothelial Cells | 1 | 2015 | 216 | 0.400 |
Why?
|
| Adenoviridae | 3 | 2022 | 132 | 0.390 |
Why?
|
| Connectome | 4 | 2025 | 42 | 0.380 |
Why?
|
| Transcranial Direct Current Stimulation | 3 | 2022 | 20 | 0.370 |
Why?
|
| Genetic Diseases, Inborn | 3 | 2022 | 37 | 0.370 |
Why?
|
| Macrophages | 1 | 2018 | 1042 | 0.370 |
Why?
|
| Aged, 80 and over | 14 | 2026 | 5681 | 0.370 |
Why?
|
| Electrocardiography | 1 | 2015 | 556 | 0.370 |
Why?
|
| Nanoparticles | 1 | 2018 | 553 | 0.360 |
Why?
|
| Designer Drugs | 1 | 2011 | 2 | 0.350 |
Why?
|
| Trisaccharides | 1 | 2011 | 8 | 0.350 |
Why?
|
| Gray Matter | 4 | 2025 | 43 | 0.350 |
Why?
|
| Child | 6 | 2026 | 4653 | 0.340 |
Why?
|
| Epilepsy | 2 | 2023 | 113 | 0.330 |
Why?
|
| Adolescent | 10 | 2026 | 6367 | 0.330 |
Why?
|
| Fibroblasts | 4 | 2023 | 423 | 0.300 |
Why?
|
| Nonsense Mediated mRNA Decay | 3 | 2022 | 26 | 0.300 |
Why?
|
| Diffusion Tensor Imaging | 3 | 2025 | 81 | 0.290 |
Why?
|
| Central Nervous System | 2 | 2023 | 205 | 0.290 |
Why?
|
| Reproducibility of Results | 6 | 2021 | 1720 | 0.270 |
Why?
|
| Macaca mulatta | 3 | 2026 | 263 | 0.270 |
Why?
|
| Healthy Volunteers | 3 | 2017 | 75 | 0.270 |
Why?
|
| Functional Neuroimaging | 2 | 2019 | 18 | 0.270 |
Why?
|
| Contrast Media | 3 | 2024 | 435 | 0.250 |
Why?
|
| Supervised Machine Learning | 1 | 2026 | 2 | 0.250 |
Why?
|
| Neuropsychological Tests | 6 | 2025 | 420 | 0.250 |
Why?
|
| Fetal Development | 1 | 2026 | 15 | 0.240 |
Why?
|
| Pregnancy Trimester, Third | 1 | 2026 | 21 | 0.240 |
Why?
|
| Oligodendroglia | 1 | 2026 | 41 | 0.240 |
Why?
|
| Models, Statistical | 3 | 2017 | 312 | 0.240 |
Why?
|
| Body Water | 1 | 2026 | 16 | 0.240 |
Why?
|
| Cognition | 3 | 2025 | 514 | 0.240 |
Why?
|
| Wakefulness | 1 | 2026 | 45 | 0.240 |
Why?
|
| Sleep Initiation and Maintenance Disorders | 1 | 2026 | 48 | 0.230 |
Why?
|
| Lumbosacral Plexus | 1 | 2025 | 7 | 0.230 |
Why?
|
| Hyperemia | 1 | 2025 | 14 | 0.230 |
Why?
|
| Brachial Artery | 1 | 2025 | 28 | 0.230 |
Why?
|
| Ferrets | 1 | 2025 | 11 | 0.230 |
Why?
|
| Microvessels | 1 | 2025 | 19 | 0.230 |
Why?
|
| Hypocapnia | 2 | 2023 | 3 | 0.230 |
Why?
|
| Clustered Regularly Interspaced Short Palindromic Repeats | 2 | 2018 | 100 | 0.230 |
Why?
|
| Amyotrophic Lateral Sclerosis | 2 | 2023 | 517 | 0.220 |
Why?
|
| Corpus Striatum | 1 | 2026 | 99 | 0.220 |
Why?
|
| S100 Calcium Binding Protein beta Subunit | 1 | 2025 | 9 | 0.220 |
Why?
|
| Receptors, Transforming Growth Factor beta | 3 | 2021 | 31 | 0.220 |
Why?
|
| Neural Pathways | 2 | 2024 | 105 | 0.220 |
Why?
|
| HEK293 Cells | 2 | 2025 | 617 | 0.220 |
Why?
|
| Dementia, Vascular | 1 | 2024 | 13 | 0.220 |
Why?
|
| Receptors, Peptide | 3 | 2021 | 34 | 0.220 |
Why?
|
| Gyrus Cinguli | 2 | 2016 | 61 | 0.220 |
Why?
|
| Sialyltransferases | 2 | 2023 | 21 | 0.210 |
Why?
|
| Cerebral Infarction | 3 | 2023 | 88 | 0.210 |
Why?
|
| Endothelium, Vascular | 1 | 2025 | 180 | 0.210 |
Why?
|
| Memory Disorders | 1 | 2024 | 53 | 0.210 |
Why?
|
| Viral Tropism | 1 | 2025 | 55 | 0.210 |
Why?
|
| Cattle | 1 | 2025 | 320 | 0.210 |
Why?
|
| Serogroup | 3 | 2025 | 35 | 0.210 |
Why?
|
| Recombinational DNA Repair | 2 | 2021 | 29 | 0.210 |
Why?
|
| History, 21st Century | 1 | 2025 | 180 | 0.200 |
Why?
|
| History, 20th Century | 1 | 2025 | 234 | 0.200 |
Why?
|
| Peptide Hormones | 1 | 2023 | 8 | 0.200 |
Why?
|
| Signal Processing, Computer-Assisted | 2 | 2021 | 101 | 0.200 |
Why?
|
| Transfection | 1 | 2025 | 700 | 0.190 |
Why?
|
| Survival of Motor Neuron 2 Protein | 1 | 2023 | 6 | 0.190 |
Why?
|
| Survival of Motor Neuron 1 Protein | 1 | 2023 | 12 | 0.190 |
Why?
|
| Sleep | 1 | 2026 | 246 | 0.190 |
Why?
|
| Muscular Atrophy, Spinal | 1 | 2023 | 25 | 0.190 |
Why?
|
| Oxadiazoles | 1 | 2022 | 8 | 0.190 |
Why?
|
| Pregnancy | 5 | 2026 | 2402 | 0.180 |
Why?
|
| Mitochondria | 1 | 2026 | 416 | 0.180 |
Why?
|
| Phantoms, Imaging | 3 | 2018 | 242 | 0.180 |
Why?
|
| Attention Deficit Disorder with Hyperactivity | 1 | 2024 | 162 | 0.180 |
Why?
|
| Gestational Age | 2 | 2026 | 196 | 0.180 |
Why?
|
| Luciferases | 1 | 2022 | 107 | 0.180 |
Why?
|
| Codon, Terminator | 1 | 2022 | 23 | 0.180 |
Why?
|
| Lung | 2 | 2024 | 969 | 0.180 |
Why?
|
| Mucopolysaccharidosis II | 1 | 2021 | 10 | 0.180 |
Why?
|
| Tyrosinemias | 1 | 2021 | 20 | 0.170 |
Why?
|
| Transducers | 1 | 2021 | 24 | 0.170 |
Why?
|
| Hereditary Sensory and Autonomic Neuropathies | 1 | 2021 | 11 | 0.170 |
Why?
|
| Spastic Paraplegia, Hereditary | 1 | 2021 | 13 | 0.170 |
Why?
|
| Neonatal Abstinence Syndrome | 1 | 2021 | 44 | 0.170 |
Why?
|
| Ovarian Follicle | 2 | 2021 | 39 | 0.170 |
Why?
|
| Frontotemporal Dementia | 1 | 2023 | 158 | 0.170 |
Why?
|
| Antidepressive Agents | 1 | 2023 | 244 | 0.160 |
Why?
|
| Moyamoya Disease | 1 | 2020 | 14 | 0.160 |
Why?
|
| Ovary | 1 | 2021 | 105 | 0.160 |
Why?
|
| Gastrointestinal Microbiome | 1 | 2025 | 273 | 0.160 |
Why?
|
| Precision Medicine | 1 | 2022 | 134 | 0.160 |
Why?
|
| Blast Injuries | 1 | 2020 | 4 | 0.160 |
Why?
|
| Diagnostic Imaging | 1 | 2023 | 274 | 0.160 |
Why?
|
| Limbic System | 1 | 2020 | 28 | 0.160 |
Why?
|
| Excitatory Amino Acid Antagonists | 1 | 2020 | 39 | 0.160 |
Why?
|
| Sensation | 1 | 2020 | 21 | 0.150 |
Why?
|
| Infant | 3 | 2021 | 1720 | 0.150 |
Why?
|
| Placental Circulation | 1 | 2019 | 2 | 0.150 |
Why?
|
| Evoked Potentials, Motor | 1 | 2019 | 22 | 0.150 |
Why?
|
| Ketamine | 1 | 2020 | 40 | 0.150 |
Why?
|
| Mullerian Ducts | 1 | 2019 | 5 | 0.150 |
Why?
|
| Uterus | 1 | 2019 | 41 | 0.150 |
Why?
|
| Peripheral Nervous System | 1 | 2019 | 13 | 0.150 |
Why?
|
| Musculoskeletal System | 1 | 2019 | 11 | 0.150 |
Why?
|
| Immunity, Humoral | 1 | 2019 | 40 | 0.150 |
Why?
|
| Bone Resorption | 1 | 2019 | 46 | 0.150 |
Why?
|
| tau Proteins | 3 | 2025 | 215 | 0.150 |
Why?
|
| Ovalbumin | 1 | 2019 | 108 | 0.150 |
Why?
|
| Adrenoleukodystrophy | 1 | 2018 | 6 | 0.150 |
Why?
|
| Genes, Reporter | 3 | 2018 | 257 | 0.140 |
Why?
|
| Military Personnel | 1 | 2020 | 111 | 0.140 |
Why?
|
| Prospective Studies | 4 | 2021 | 3339 | 0.140 |
Why?
|
| Recombinant Proteins | 1 | 2021 | 709 | 0.140 |
Why?
|
| Glutamic Acid | 2 | 2016 | 105 | 0.140 |
Why?
|
| Endonucleases | 2 | 2018 | 84 | 0.140 |
Why?
|
| Hand | 2 | 2019 | 79 | 0.140 |
Why?
|
| Schizophrenic Psychology | 2 | 2016 | 76 | 0.140 |
Why?
|
| DNA End-Joining Repair | 2 | 2018 | 26 | 0.140 |
Why?
|
| Brain Injuries, Traumatic | 1 | 2020 | 97 | 0.140 |
Why?
|
| Elasticity Imaging Techniques | 1 | 2018 | 28 | 0.140 |
Why?
|
| Immunity, Cellular | 1 | 2019 | 170 | 0.140 |
Why?
|
| Osteoporosis | 1 | 2019 | 113 | 0.140 |
Why?
|
| Gelatin | 1 | 2018 | 32 | 0.140 |
Why?
|
| Infusion Pumps, Implantable | 1 | 2018 | 6 | 0.140 |
Why?
|
| Mice, Transgenic | 4 | 2018 | 1291 | 0.140 |
Why?
|
| Infusions, Intraventricular | 1 | 2018 | 12 | 0.140 |
Why?
|
| Osmotic Pressure | 1 | 2018 | 17 | 0.140 |
Why?
|
| Bone and Bones | 1 | 2019 | 152 | 0.140 |
Why?
|
| Cerebrospinal Fluid | 1 | 2018 | 29 | 0.130 |
Why?
|
| Catheters, Indwelling | 1 | 2018 | 67 | 0.130 |
Why?
|
| Models, Cardiovascular | 1 | 2018 | 84 | 0.130 |
Why?
|
| Infant, Newborn | 2 | 2021 | 1441 | 0.130 |
Why?
|
| Pregnancy Trimester, Second | 1 | 2017 | 37 | 0.130 |
Why?
|
| Heart Failure | 2 | 2017 | 966 | 0.130 |
Why?
|
| Diastole | 1 | 2017 | 91 | 0.130 |
Why?
|
| Inverted Repeat Sequences | 1 | 2017 | 14 | 0.130 |
Why?
|
| Swine | 1 | 2018 | 398 | 0.130 |
Why?
|
| Hypertension | 1 | 2023 | 618 | 0.130 |
Why?
|
| Oxygen | 2 | 2016 | 323 | 0.130 |
Why?
|
| Ovarian Reserve | 1 | 2017 | 9 | 0.130 |
Why?
|
| alpha 1-Antitrypsin | 1 | 2018 | 91 | 0.130 |
Why?
|
| Meningeal Neoplasms | 1 | 2017 | 63 | 0.130 |
Why?
|
| Meningioma | 1 | 2017 | 65 | 0.130 |
Why?
|
| Biological Transport | 1 | 2018 | 292 | 0.130 |
Why?
|
| Meninges | 1 | 2017 | 11 | 0.130 |
Why?
|
| alpha 1-Antitrypsin Deficiency | 1 | 2018 | 70 | 0.130 |
Why?
|
| Cell Line | 2 | 2018 | 2031 | 0.130 |
Why?
|
| Contraceptive Agents | 1 | 2017 | 12 | 0.130 |
Why?
|
| Reperfusion | 1 | 2017 | 38 | 0.130 |
Why?
|
| Interoception | 1 | 2016 | 3 | 0.120 |
Why?
|
| Acceleration | 1 | 2017 | 36 | 0.120 |
Why?
|
| Genetic Engineering | 1 | 2018 | 114 | 0.120 |
Why?
|
| Respiratory Rate | 1 | 2016 | 17 | 0.120 |
Why?
|
| Isoproterenol | 1 | 2016 | 38 | 0.120 |
Why?
|
| Diabetic Nephropathies | 1 | 2017 | 39 | 0.120 |
Why?
|
| Adrenergic beta-Agonists | 1 | 2016 | 35 | 0.120 |
Why?
|
| Embryonic Development | 1 | 2018 | 142 | 0.120 |
Why?
|
| Observer Variation | 1 | 2017 | 217 | 0.120 |
Why?
|
| Analgesics, Opioid | 1 | 2021 | 533 | 0.120 |
Why?
|
| Pediatrics | 1 | 2019 | 265 | 0.120 |
Why?
|
| ROC Curve | 1 | 2017 | 295 | 0.120 |
Why?
|
| Child, Preschool | 2 | 2019 | 2088 | 0.120 |
Why?
|
| Gene Silencing | 1 | 2019 | 439 | 0.120 |
Why?
|
| Superoxide Dismutase | 1 | 2017 | 223 | 0.120 |
Why?
|
| DNA, Viral | 1 | 2017 | 232 | 0.120 |
Why?
|
| Genome, Viral | 1 | 2017 | 145 | 0.120 |
Why?
|
| Compliance | 1 | 2015 | 6 | 0.120 |
Why?
|
| Arterioles | 1 | 2015 | 8 | 0.120 |
Why?
|
| Hemodynamics | 1 | 2017 | 253 | 0.120 |
Why?
|
| Pulse Wave Analysis | 1 | 2015 | 16 | 0.120 |
Why?
|
| Infarction, Middle Cerebral Artery | 1 | 2017 | 99 | 0.110 |
Why?
|
| Shear Strength | 1 | 2015 | 20 | 0.110 |
Why?
|
| Thrombolytic Therapy | 1 | 2017 | 205 | 0.110 |
Why?
|
| Arterial Pressure | 1 | 2015 | 30 | 0.110 |
Why?
|
| Stress, Mechanical | 1 | 2015 | 119 | 0.110 |
Why?
|
| Targeted Gene Repair | 1 | 2014 | 3 | 0.110 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2015 | 203 | 0.110 |
Why?
|
| Heart Rate | 1 | 2016 | 335 | 0.110 |
Why?
|
| Multimodal Imaging | 2 | 2025 | 74 | 0.110 |
Why?
|
| Prostate | 1 | 2015 | 124 | 0.110 |
Why?
|
| Cohort Studies | 2 | 2024 | 2649 | 0.110 |
Why?
|
| Cardiovascular Diseases | 1 | 2022 | 876 | 0.110 |
Why?
|
| RNA Editing | 1 | 2014 | 27 | 0.110 |
Why?
|
| Isoflurane | 1 | 2014 | 17 | 0.100 |
Why?
|
| Brain Neoplasms | 1 | 2017 | 321 | 0.100 |
Why?
|
| Mental Disorders | 1 | 2022 | 827 | 0.100 |
Why?
|
| Regional Blood Flow | 1 | 2014 | 117 | 0.100 |
Why?
|
| Base Sequence | 2 | 2019 | 1332 | 0.100 |
Why?
|
| Clinical Trials as Topic | 2 | 2014 | 462 | 0.100 |
Why?
|
| Atrophy | 2 | 2025 | 89 | 0.100 |
Why?
|
| Gene Knockdown Techniques | 1 | 2014 | 206 | 0.100 |
Why?
|
| Cells, Cultured | 2 | 2015 | 2194 | 0.100 |
Why?
|
| Ovarian Neoplasms | 1 | 2015 | 170 | 0.100 |
Why?
|
| gamma-Aminobutyric Acid | 1 | 2014 | 77 | 0.100 |
Why?
|
| Bacterial Proteins | 2 | 2018 | 741 | 0.100 |
Why?
|
| Lumbar Vertebrae | 1 | 2015 | 178 | 0.100 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2021 | 1665 | 0.100 |
Why?
|
| RNA Splicing | 1 | 2014 | 173 | 0.100 |
Why?
|
| Oligonucleotides, Antisense | 1 | 2014 | 154 | 0.100 |
Why?
|
| Positron-Emission Tomography | 2 | 2025 | 233 | 0.090 |
Why?
|
| DNA-Binding Proteins | 1 | 2019 | 1226 | 0.090 |
Why?
|
| MicroRNAs | 1 | 2019 | 714 | 0.090 |
Why?
|
| Peptide Chain Termination, Translational | 1 | 2012 | 18 | 0.090 |
Why?
|
| Gene Expression Profiling | 2 | 2019 | 799 | 0.090 |
Why?
|
| Antineoplastic Agents | 1 | 2017 | 645 | 0.090 |
Why?
|
| Biological Assay | 1 | 2011 | 56 | 0.090 |
Why?
|
| Embryo, Mammalian | 1 | 2011 | 158 | 0.080 |
Why?
|
| Prostatic Neoplasms | 1 | 2015 | 502 | 0.080 |
Why?
|
| RNA Interference | 1 | 2014 | 647 | 0.080 |
Why?
|
| Lysosomes | 1 | 2011 | 176 | 0.080 |
Why?
|
| Endovascular Procedures | 1 | 2017 | 633 | 0.080 |
Why?
|
| Retrospective Studies | 2 | 2019 | 6953 | 0.080 |
Why?
|
| Mice, Inbred Strains | 1 | 2010 | 185 | 0.080 |
Why?
|
| Femur | 1 | 2010 | 56 | 0.080 |
Why?
|
| Absorptiometry, Photon | 1 | 2010 | 76 | 0.080 |
Why?
|
| Contraception | 2 | 2023 | 72 | 0.080 |
Why?
|
| Microscopy, Electron | 1 | 2010 | 254 | 0.070 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2010 | 129 | 0.070 |
Why?
|
| Bone Density | 1 | 2010 | 142 | 0.070 |
Why?
|
| Nerve Net | 2 | 2020 | 105 | 0.070 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2010 | 542 | 0.070 |
Why?
|
| Spleen | 1 | 2010 | 476 | 0.070 |
Why?
|
| Survival Analysis | 1 | 2010 | 579 | 0.070 |
Why?
|
| Injections, Spinal | 2 | 2018 | 44 | 0.070 |
Why?
|
| Molecular Sequence Data | 1 | 2011 | 1980 | 0.070 |
Why?
|
| RNA, Messenger | 1 | 2013 | 1583 | 0.060 |
Why?
|
| Reference Values | 2 | 2019 | 330 | 0.060 |
Why?
|
| Entropy | 1 | 2026 | 25 | 0.060 |
Why?
|
| Pattern Recognition, Automated | 1 | 2026 | 53 | 0.060 |
Why?
|
| Fetal Growth Retardation | 1 | 2026 | 22 | 0.060 |
Why?
|
| Microbubbles | 1 | 2026 | 4 | 0.060 |
Why?
|
| Green Fluorescent Proteins | 2 | 2018 | 372 | 0.060 |
Why?
|
| Sonication | 1 | 2026 | 16 | 0.060 |
Why?
|
| Treatment Outcome | 1 | 2017 | 5830 | 0.060 |
Why?
|
| Polysomnography | 1 | 2026 | 61 | 0.060 |
Why?
|
| Metabolomics | 1 | 2026 | 64 | 0.060 |
Why?
|
| Artifacts | 2 | 2017 | 130 | 0.060 |
Why?
|
| Factor Analysis, Statistical | 1 | 2025 | 103 | 0.060 |
Why?
|
| Parahippocampal Gyrus | 1 | 2024 | 2 | 0.050 |
Why?
|
| Mental Status and Dementia Tests | 1 | 2024 | 20 | 0.050 |
Why?
|
| Diffusion | 1 | 2024 | 83 | 0.050 |
Why?
|
| High-Temperature Requirement A Serine Peptidase 1 | 1 | 2024 | 10 | 0.050 |
Why?
|
| Temporal Lobe | 1 | 2024 | 47 | 0.050 |
Why?
|
| China | 1 | 2025 | 181 | 0.050 |
Why?
|
| Social Networking | 1 | 2024 | 24 | 0.050 |
Why?
|
| Tissue Distribution | 1 | 2025 | 292 | 0.050 |
Why?
|
| Apolipoproteins E | 1 | 2024 | 116 | 0.050 |
Why?
|
| Systems Analysis | 1 | 2024 | 12 | 0.050 |
Why?
|
| Neoplasms | 1 | 2014 | 1377 | 0.050 |
Why?
|
| Psychomotor Performance | 2 | 2015 | 139 | 0.050 |
Why?
|
| Behavioral Symptoms | 1 | 2024 | 18 | 0.050 |
Why?
|
| Geriatric Assessment | 1 | 2024 | 163 | 0.050 |
Why?
|
| Population Control | 1 | 2023 | 2 | 0.050 |
Why?
|
| Amyloidogenic Proteins | 1 | 2023 | 14 | 0.050 |
Why?
|
| Sterilization, Reproductive | 1 | 2023 | 10 | 0.050 |
Why?
|
| Gadolinium | 1 | 2024 | 111 | 0.050 |
Why?
|
| Animals, Wild | 1 | 2023 | 15 | 0.050 |
Why?
|
| Macaca fascicularis | 1 | 2023 | 48 | 0.050 |
Why?
|
| Gangliosides | 1 | 2023 | 19 | 0.050 |
Why?
|
| Risk | 1 | 2024 | 375 | 0.050 |
Why?
|
| Cats | 1 | 2023 | 92 | 0.050 |
Why?
|
| Arthrogryposis | 1 | 2023 | 3 | 0.050 |
Why?
|
| Neurofibrillary Tangles | 1 | 2023 | 12 | 0.050 |
Why?
|
| Dipeptides | 1 | 2023 | 69 | 0.050 |
Why?
|
| DNA Repeat Expansion | 1 | 2023 | 59 | 0.050 |
Why?
|
| Amyloid beta-Protein Precursor | 1 | 2023 | 88 | 0.050 |
Why?
|
| Cell Line, Tumor | 2 | 2018 | 1573 | 0.050 |
Why?
|
| Vasodilation | 1 | 2022 | 36 | 0.050 |
Why?
|
| Genotype | 1 | 2024 | 676 | 0.050 |
Why?
|
| Risk Factors | 2 | 2023 | 5471 | 0.050 |
Why?
|
| Iron | 1 | 2023 | 156 | 0.050 |
Why?
|
| C9orf72 Protein | 1 | 2023 | 115 | 0.050 |
Why?
|
| Rare Diseases | 1 | 2022 | 45 | 0.040 |
Why?
|
| Neurologic Examination | 1 | 2021 | 55 | 0.040 |
Why?
|
| United States Food and Drug Administration | 1 | 2022 | 92 | 0.040 |
Why?
|
| Motor Neurons | 1 | 2023 | 219 | 0.040 |
Why?
|
| Tomography | 1 | 2021 | 9 | 0.040 |
Why?
|
| Age Factors | 1 | 2025 | 1595 | 0.040 |
Why?
|
| Inhibins | 1 | 2021 | 50 | 0.040 |
Why?
|
| Amyloid beta-Peptides | 1 | 2023 | 323 | 0.040 |
Why?
|
| Proteomics | 1 | 2023 | 299 | 0.040 |
Why?
|
| Sex Characteristics | 1 | 2022 | 216 | 0.040 |
Why?
|
| Animals, Newborn | 1 | 2021 | 241 | 0.040 |
Why?
|
| Anhedonia | 1 | 2020 | 10 | 0.040 |
Why?
|
| Afghan Campaign 2001- | 1 | 2020 | 67 | 0.040 |
Why?
|
| Iraq War, 2003-2011 | 1 | 2020 | 62 | 0.040 |
Why?
|
| Depressive Disorder, Treatment-Resistant | 1 | 2020 | 7 | 0.040 |
Why?
|
| Single-Cell Analysis | 1 | 2021 | 119 | 0.040 |
Why?
|
| Blood Pressure | 1 | 2023 | 537 | 0.040 |
Why?
|
| Apathy | 1 | 2020 | 10 | 0.040 |
Why?
|
| Biological Variation, Individual | 1 | 2019 | 3 | 0.040 |
Why?
|
| Prefrontal Cortex | 1 | 2021 | 129 | 0.040 |
Why?
|
| Sequence Analysis, RNA | 1 | 2021 | 182 | 0.040 |
Why?
|
| Brain Concussion | 1 | 2020 | 38 | 0.040 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2021 | 626 | 0.040 |
Why?
|
| Electromyography | 1 | 2019 | 100 | 0.040 |
Why?
|
| Cartilage | 1 | 2019 | 35 | 0.040 |
Why?
|
| Fertility | 1 | 2019 | 85 | 0.040 |
Why?
|
| Double-Blind Method | 1 | 2021 | 747 | 0.040 |
Why?
|
| Antibody Formation | 1 | 2019 | 111 | 0.040 |
Why?
|
| Affect | 1 | 2020 | 132 | 0.040 |
Why?
|
| Viscosity | 1 | 2018 | 62 | 0.030 |
Why?
|
| Elasticity | 1 | 2018 | 47 | 0.030 |
Why?
|
| Antigen-Presenting Cells | 1 | 2019 | 180 | 0.030 |
Why?
|
| T-Lymphocytes, Cytotoxic | 1 | 2019 | 169 | 0.030 |
Why?
|
| Neuronal Plasticity | 1 | 2020 | 155 | 0.030 |
Why?
|
| Osteoblasts | 1 | 2019 | 204 | 0.030 |
Why?
|
| Fallopian Tubes | 1 | 2018 | 13 | 0.030 |
Why?
|
| Gene Deletion | 1 | 2019 | 312 | 0.030 |
Why?
|
| Astrocytes | 1 | 2018 | 123 | 0.030 |
Why?
|
| Adenomatous Polyposis Coli Protein | 1 | 2017 | 10 | 0.030 |
Why?
|
| Self Report | 1 | 2020 | 395 | 0.030 |
Why?
|
| Ganglia, Spinal | 1 | 2017 | 30 | 0.030 |
Why?
|
| Glial Fibrillary Acidic Protein | 1 | 2017 | 42 | 0.030 |
Why?
|
| Proteins | 1 | 2023 | 764 | 0.030 |
Why?
|
| Homeodomain Proteins | 1 | 2019 | 277 | 0.030 |
Why?
|
| Mice, Inbred BALB C | 1 | 2019 | 869 | 0.030 |
Why?
|
| Electron Spin Resonance Spectroscopy | 1 | 2017 | 24 | 0.030 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2018 | 252 | 0.030 |
Why?
|
| Rats | 1 | 2021 | 2005 | 0.030 |
Why?
|
| Renal Circulation | 1 | 2017 | 15 | 0.030 |
Why?
|
| Blastocyst | 1 | 2018 | 74 | 0.030 |
Why?
|
| Gene Order | 1 | 2017 | 33 | 0.030 |
Why?
|
| Calcium-Binding Proteins | 1 | 2017 | 95 | 0.030 |
Why?
|
| Granulosa Cells | 1 | 2017 | 18 | 0.030 |
Why?
|
| Primary Ovarian Insufficiency | 1 | 2017 | 8 | 0.030 |
Why?
|
| Transcription, Genetic | 1 | 2021 | 910 | 0.030 |
Why?
|
| Sequence Deletion | 1 | 2017 | 115 | 0.030 |
Why?
|
| Microfilament Proteins | 1 | 2017 | 115 | 0.030 |
Why?
|
| Proton Magnetic Resonance Spectroscopy | 1 | 2016 | 13 | 0.030 |
Why?
|
| Lymphocyte Activation | 1 | 2019 | 755 | 0.030 |
Why?
|
| Glomerular Filtration Rate | 1 | 2017 | 122 | 0.030 |
Why?
|
| Reproduction | 1 | 2017 | 100 | 0.030 |
Why?
|
| Plasmids | 1 | 2017 | 294 | 0.030 |
Why?
|
| Glutamine | 1 | 2016 | 51 | 0.030 |
Why?
|
| Dendritic Cells | 1 | 2019 | 534 | 0.030 |
Why?
|
| Nucleic Acid Conformation | 1 | 2017 | 241 | 0.030 |
Why?
|
| Pilot Projects | 1 | 2019 | 1029 | 0.030 |
Why?
|
| Body Weight | 1 | 2017 | 377 | 0.030 |
Why?
|
| Serotyping | 1 | 2015 | 52 | 0.030 |
Why?
|
| Cell Differentiation | 1 | 2021 | 1391 | 0.030 |
Why?
|
| Tropism | 1 | 2015 | 15 | 0.030 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2016 | 279 | 0.030 |
Why?
|
| Spheroids, Cellular | 1 | 2015 | 28 | 0.030 |
Why?
|
| Sequence Analysis, DNA | 1 | 2017 | 417 | 0.030 |
Why?
|
| Ascites | 1 | 2015 | 22 | 0.030 |
Why?
|
| Tissue Array Analysis | 1 | 2015 | 39 | 0.030 |
Why?
|
| Tumor Burden | 1 | 2015 | 77 | 0.030 |
Why?
|
| Lidocaine | 1 | 2015 | 33 | 0.030 |
Why?
|
| Somatosensory Cortex | 1 | 2015 | 21 | 0.030 |
Why?
|
| Injections | 1 | 2015 | 84 | 0.030 |
Why?
|
| Eye | 1 | 2015 | 60 | 0.030 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2017 | 378 | 0.030 |
Why?
|
| Punctures | 1 | 2015 | 63 | 0.030 |
Why?
|
| Reference Standards | 1 | 2015 | 77 | 0.030 |
Why?
|
| DNA Replication | 1 | 2017 | 250 | 0.030 |
Why?
|
| Cytokines | 1 | 2019 | 964 | 0.030 |
Why?
|
| Memory, Short-Term | 1 | 2015 | 67 | 0.030 |
Why?
|
| Organ Specificity | 1 | 2015 | 200 | 0.030 |
Why?
|
| Multicenter Studies as Topic | 1 | 2015 | 162 | 0.030 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2019 | 679 | 0.030 |
Why?
|
| Computer Simulation | 1 | 2017 | 488 | 0.030 |
Why?
|
| Anesthetics, Inhalation | 1 | 2014 | 19 | 0.030 |
Why?
|
| Carcinogenesis | 1 | 2015 | 135 | 0.030 |
Why?
|
| Functional Laterality | 1 | 2014 | 141 | 0.030 |
Why?
|
| Depression | 1 | 2021 | 910 | 0.030 |
Why?
|
| Gene Expression | 1 | 2017 | 855 | 0.030 |
Why?
|
| Administration, Inhalation | 1 | 2014 | 161 | 0.020 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2015 | 503 | 0.020 |
Why?
|
| Recovery of Function | 1 | 2014 | 293 | 0.020 |
Why?
|
| Protein Synthesis Inhibitors | 1 | 2012 | 23 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2014 | 859 | 0.020 |
Why?
|
| Models, Biological | 1 | 2017 | 1193 | 0.020 |
Why?
|
| Cystic Fibrosis Transmembrane Conductance Regulator | 1 | 2012 | 81 | 0.020 |
Why?
|
| Motor Activity | 1 | 2014 | 347 | 0.020 |
Why?
|
| Biomarkers, Tumor | 1 | 2015 | 526 | 0.020 |
Why?
|
| Cell Proliferation | 1 | 2015 | 1044 | 0.020 |
Why?
|
| Longitudinal Studies | 1 | 2014 | 1291 | 0.020 |
Why?
|
| RNA, Small Interfering | 1 | 2017 | 993 | 0.020 |
Why?
|
| Smoking | 1 | 2015 | 864 | 0.020 |
Why?
|
| Protein Biosynthesis | 1 | 2012 | 333 | 0.020 |
Why?
|
| United States | 1 | 2022 | 8190 | 0.020 |
Why?
|
| Inflammation | 1 | 2015 | 1198 | 0.020 |
Why?
|
| Cross-Sectional Studies | 1 | 2014 | 2737 | 0.020 |
Why?
|
| Signal Transduction | 1 | 2015 | 3168 | 0.010 |
Why?
|